Clinical outcomes of pediatric patients with congenital toxoplasmosis in a fourthlevel center Introduction. Congenital

Sebastián Posada-Bustos, Ana Cristina Mariño , Eugenia Espinosa-García , .

Keywords: Toxoplasma, toxoplasmosis, congenital, toxoplasmosis, chorioretinitis, neurodevelopmental disorders, intellectual disability, Colombia

Abstract

Introduction. Congenital toxoplasmosis is a highly prevalent parasitic disease worldwide, with a high burden of disease and neurodevelopmental involvement in pediatric patients.
Objective. To describe the clinical sequelae and neurodevelopmental state of pediatric patients with congenital toxoplasmosis at the Hospital Militar Central during 2013 to 2020.
Materials and methods. We conducted an observational, descriptive, cross-sectional study with an analytical component, including pediatric patients diagnosed with congenital toxoplasmosis. Patients consulted the Hospital Militar Central from January 2013 to December 2020. The Ages and Stages Questionnaires 3 neurodevelopmental scale was applied to children under six years old.
Results. Forty-five patients with confirmed congenital toxoplasmosis were included, with a mean age of 5.9 years; 60% were male; 11.2 % were symptomatic at birth, and 33% presented chorioretinitis. During the follow-up, 73% presented ophthalmologic sequelae, 64% cerebral calcifications, 4.4% hydrocephalus, 11.2% cerebral palsy, and 13.4% focal epilepsy. In children under six years old, 58% presented neurodevelopmental compromise, and in those over six years old, 62% had cognitive deficits. In this cohort, 68% of the patients received posnatal treatment, with a statistically significant association between not receiving treatment and ophthalmological sequelae (OR = 5.2; p < 0.001).
Conclusions. Congenital toxoplasmosis is associated with important long-term sequelae similar to those described in several Latin American series. These findings highlight the importance of early diagnosis, evaluation, treatment, and timely interdisciplinary follow-up of patients in our country to improve their prognosis.

Downloads

Download data is not yet available.
  • Sebastián Posada-Bustos Servicio de Neurología Pediátrica, Hospital Militar Central, Facultad de Medicina, Universidad Militar Nueva Granada, Bogotá, D. C., Colombia https://orcid.org/0009-0008-8390-7973
  • Ana Cristina Mariño Servicio de Infectología Pediátrica, Hospital Militar Central, Facultad de Medicina, Universidad Militar Nueva Granada, Bogotá, D. C., Colombia https://orcid.org/0000-0002-8747-5919
  • Eugenia Espinosa-García Servicio de Infectología Pediátrica, Hospital Militar Central, Facultad de Medicina, Universidad Militar Nueva Granada, Bogotá, D. C., Colombia https://orcid.org/0000-0003-0890-6475

References

Dubey JP. Sources of Toxoplasma gondii infection in pregnancy. Until rates of congenital toxoplasmosis fall, control measures are essential. BMJ. 2000;321:127-8. https://doi.org/10.1136/bmj.321.7254.127

Khan K, Khan W. Congenital toxoplasmosis: An overview of the neurological and ocular manifestations. Parasitol Int. 2018;67:715-21. https://doi.org/10.1016/j.parint.2018.07.004

Maldonado YA, Read JS; Committee on Infectious Diseases. Diagnosis, treatment, and prevention of congenital toxoplasmosis in the United States. Pediatrics. 2017;139:e20163860. https://doi.org/10.1542/peds.2016-3860

Gilbert R. Epidemiology of infection in pregnant women. In: Ambroise-Thomas P, Petersen E, editors. Congenital toxoplasmosis. Scientific background, clinical management and control. Paris: Springer-Verlag; 2000. p. 237-49.

Cañón-Franco WA, López-Orozco N, Gómez-Marín JE, Dubey JP. An overview of seventy years of research (1944-2014) on toxoplasmosis in Colombia, South America. Parasit Vectors. 2014;4;7:427. https://doi.org/10.1186/1756-3305-7-427

Pérez-Grisales LJ, Cruz-Moncada M, Peláez-Sánchez RG, Díaz-Nieto JF. Toxoplasma gondii infection in Colombia with a review of hosts and their ecogeographic distribution. Zoonoses Public Health. 2021;68:38-53. https://doi.org/10.1111/zph.12787

Cortés JA, Gómez JE, Silva PI, Arévalo L, Arévalo-Rodríguez I, Álvarez MI, et al. Guía de atención integral para la prevención, detección temprana y tratamiento de las complicaciones del embarazo, parto y puerperio: sección toxoplasmosis en el embarazo. Infectio. 2012;16:230-46. https://doi.org/10.22354/in.v21i2

Squires J, Bricker D. Ages & Stages Questionnaires. Third edition. (ASQ-3): A parent-completed child- monitoring system. 2009. Stanford: Paul Brookes Publishing Company. 2009. p. 1-191.

Singh A, Yeh CJ, Boone-Blanchard S. Ages and stages questionnaire: A global screening scale. Bol Med Hosp Infant Mex. 2017;74:5-12. https://doi.org/10.1016/j.bmhimx.2016.07.008

Chqnhaut BL, Armijo RI. Aplicabilidad del Ages & Stages Questionnaires para el tamizaje del desarrollo psicomotor. Rev Chil Pediatr. 2014;85:12-21. https://doi.org/10.4067/S0370-41062014000100002

Gómez-Marín JE. Evaluación del tratamiento de la toxoplasmosis gestacional en una cohorte colombiana. Infectio. 2005;9:16-23.

Gómez-Marín JE, Castaño JC, Montoya-Londoño MT, Loango N, López C, Sarmiento MC, et al. Toxoplasmosis congénita en Colombia: análisis clínico y de laboratorio en 27 casos. Pediatría. 2000;35:52-7.

Mejía-Oquendo M, Marulanda-Ibarra E, Gómez-Marín JE. Evaluation of the impact of the first evidence-based guidelines for congenital toxoplasmosis in Armenia (Quindío) Colombia: An observational retrospective analysis. Lancet Reg Health Am. 2021;1:100010. https://doi.org/doi:10.1016/j.lana.2021.100010

Neto EC, Amorim F, Lago EG. Estimation of the regional distribution of congenital toxoplasmosis in Brazil from the results of neonatal screening. Sci Med. 2010;20:64-70.

Dubey JP, Lago EG, Gennari SM, Su C, Jones JL. Toxoplasmosis in humans and animals in Brazil: High prevalence, high burden of disease, and epidemiology. Parasitology. 2012;139:1375-424. https://doi.org/10.1017/S0031182012000765

Gómez-Marín JE, de-la-Torre A, Ángel-Muller E, Rubio J, Arenas J, Osorio E, et al. First Colombian multicentric newborn screening for congenital toxoplasmosis. PLoS Negl Trop Dis. 2011;5:e1195. https://doi.org/10.1371/journal.pntd.0001195

Jones JL, Muccioli C, Belfort R Jr, Holland GN, Roberts JM, Silveira C. Recently acquired Toxoplasma gondii infection, Brazil. Emerg Infect Dis. 2006;12:582-6. https://doi.org/10.3201/eid1204.051081

Zuluaga LM, Hernández JC, Castaño CF, Donado JH. Effect of antenatal spiramycin treatment on the frequency of retinochoroiditis due to congenital toxoplasmosis in a Colombian cohort. Biomédica. 2017;37:86-91. https://doi.org/10.7705/biomedica.v37i2.2818

Bartholo BB, Monteiro DL, Rodrigues NC, Trajano AJ, Jesus N, Cardoso FF, et al. Treatment of acute toxoplasmosis in pregnancy: Influence in the mother-to-child transmission. J Obstet Gynaecol Can. 2020;42:1505-10. https://doi.org/10.1016/j.jogc.2020.04.021

Cruz-Agudelo DC, Bedoya-Vélez M, Rodríguez-Padilla LM, Campo-Campo MN, Sanín-Blair JE, Londoño-Montoya JA, et al. Toxoplasmosis gestacional: desenlaces obstétricos y resultados perinatales en un hospital de referencia en Medellín, Colombia. 2015-2021. Un estudio descriptivo. Infectio. 2023;27:223-9 https://doi.org/10.22354/24223794.115

McLeod R, Boyer K, Karrison T, Kasza K, Swisher C, Roizen N, et al. Outcome of treatment for congenital toxoplasmosis, 1981-2004: The National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis. 2006;42:1383-94. https://doi.org/10.1086/501360

Gilbert RE, Freeman K, Lago EG, Bahia-Oliveira LM, Tan HK, Wallon M, et al. European Multicentre Study on Congenital Toxoplasmosis (EMSCOT). Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis. 2008;2:e277. https://doi.org/10.1371/journal.pntd.0000277

Vasconcelos-Santos DV, Machado-Azevedo DO, Campos WR, Oréfice F, Queiroz-Andrade GM, Carellos EV, et al. UFMG Congenital Toxoplasmosis Brazilian Group. Congenital toxoplasmosis in Southeastern Brazil: Results of early ophthalmologic examination of a large cohort of neonates. Ophthalmology. 2009;116:2199-205.e1. https://doi.org/10.1016/j.ophtha.2009.04.042

Olariu TR, Remington JS, McLeod R, Alam A, Montoya JG. Severe congenital toxoplasmosis in the United States: Clinical and serologic findings in untreated infants. Pediatr Infect Dis J. 2011;30:1056-61. https://doi.org/10.1086/501360

Berrebi A, Assouline C, Bessières MH, Lathière M, Cassaing S, Minville V, et al. Long-term outcome of children with congenital toxoplasmosis. Am J Obstet Gynecol. 2010;203:552,e1-6. https://doi.org/10.1016/j.ajog.2010.06.002

Thiébaut R, Leproust S, Chêne G, Gilbert R; SYROCOT (Systematic Review on Congenital Toxoplasmosis) Study Group. Effectiveness of prenatal treatment for congenital toxoplasmosis: A meta-analysis of individual patients’ data. Lancet. 2007;369:115-22. https://doi.org/10.1016/S0140-6736(07)60072-5

Peyron F, Lobry JR, Musset K, Ferrandiz J, Gómez-Marín JE, Petersen E, et al. Serotyping of Toxoplasma gondii in chronically infected pregnant women: Predominance of type II in Europe and types I and III in Colombia (South America). Microbes Infect. 2006;8:2333-40. https://doi.org/10.1016/j.micinf.2006.03.023

Cortina-Borja M, Tan HK, Wallon M, Paul M, Prusa A, Buffolano W, et al. European Multicentre Study on Congenital Toxoplasmosis (EMSCOT). Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: An observational prospective cohort study. PLoS Med. 2010;7:e1000351. https://doi.org/10.1371/journal.pmed.1000351

Roizen N, Swisher CN, Stein MA, Hopkins J, Boyer KM, Holfels E, et al. Neurologic and developmental outcome in treated congenital toxoplasmosis. Pediatrics. 1995;95:11-20.

Patel DV, Holfels EM, Vogel NP, Boyer KM, Mets MB, Swisher CN, et al. Resolution of intracranial calcifications in infants with treated congenital toxoplasmosis. Radiology. 1996;199:433-40. https://doi.org/10.1148/radiology.199.2.8668790

Phan L, Kasza K, Jalbrzikowski J, Noble AG, Latkany P, Kuo A, et al. Toxoplasmosis Study Group. Longitudinal study of new eye lesions in treated congenital toxoplasmosis. Ophthalmology. 2008;115:553-9. https://doi.org/10.1016/j.ophtha.2007.06.022

How to Cite
1.
Posada-Bustos S, Mariño AC, Espinosa-García E. Clinical outcomes of pediatric patients with congenital toxoplasmosis in a fourthlevel center Introduction. Congenital. Biomed. [Internet]. 2024 Nov. 6 [cited 2025 Apr. 4];44(4):496-509. Available from: https://revistabiomedicaorg.biteca.online/index.php/biomedica/article/view/7206

Some similar items:

Published
2024-11-06
Section
Original articles

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo
QR Code